GlassScriptPhysician profile
Martha P Rodriguez
NPI 1780037978
$34,676.87
in general payments reported to CMS, 2019-2025
14 companies · $5,008 in 2025
The $5,008 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,843 · 2022: $11K · 2023: $7,137 · 2024: $9,086 · 2025: $5,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $5,785 · Food and Beverage: $3,817 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,070.00 |
| Travel and Lodging | $5,785.32 |
| Food and Beverage | $3,816.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,560.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $16,626.08 | 2021-2025 | Cabenuva, Dovato, Apretude |
| Gilead Sciences, INC. | $16,406.84 | 2021-2025 | Yeztugo, Descovy, Epclusa |
| Janssen Biotech, INC. | $299.16 | 2021-2022 | |
| Theratechnologies INC. | $232.22 | 2021-2024 | Egrifta, Trogarzo, Egrifta Sv |
| Dexcom, INC. | $191.77 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $163.72 | 2025 | Freestyle Libre 3 |
| Janssen Products, LP | $148.95 | 2021 | |
| Novo Nordisk INC | $132.36 | 2024 | |
| Inspire Medical Systems, INC. | $118.52 | 2025 | Inspire |
| Blueprint Medicines Corporation | $112.40 | 2024 | Ayvakit |
| Sage Therapeutics, LLC | $100.00 | 2025 | |
| Emd Serono, INC. | $71.58 | 2023-2025 | Serostim |
| Nevro Corp. | $40.08 | 2024 | Senza |
| Merck Sharp & Dohme LLC | $33.19 | 2021-2023 | Delstrigo, Pifeltro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.